• 제목/요약/키워드: Laboratory of nuclear medicine

검색결과 472건 처리시간 0.028초

SPECT를 이용한 간용적의 측정 (Measurement of Liver Volume by Emission Computed Tomography)

  • 유형식;이종태;박창윤;우광방;백남칠;신동호;주기환
    • 대한핵의학회지
    • /
    • 제17권1호
    • /
    • pp.55-62
    • /
    • 1983
  • In 16 volunteers without clinical or laboratory evidence of liver disease, liver volume was determined using single-photon emission computed tomography(ECT). This technique provided excellent object contrast between the liver and its surroundings and permitted calculation of liver volume without geometric assumptions about the liver's configuration. Reproducibility of results was satisfactory, with a root-me an-square error of less than 2% between duplicate measurements in 16 individuals. The volume measurements were validated by the use of phantoms.

  • PDF

흰쥐 육종 180에서 $^{169}Yb-Citrate$의 종양 친화성 (Accumulation of $^{l69}Yb$ Citrate in Tumor Bearing Mice)

  • 김장휘;홍성운;임상무;이진오
    • 대한핵의학회지
    • /
    • 제22권1호
    • /
    • pp.77-81
    • /
    • 1988
  • Tumor localizing properties of $^{67}Ga$ citrate and $^{169}Yb$ citrate were studies with sarcoma 180 bearing mice. To compare precisely the accumulation of $^{67}Ga$ citrate and $^{169}Yb$ citrate in tumor tissue itself, $^{67}Ga$ and l63yb were administered simultaneously as a mixture of same chemical form of citrate. The yield of $^{169}Yb$ labeled citrated and the of radiopharmaceuticals purity was identified more than 90% by chromatography on silica gel plates. $^{67}Ga$ and $^{169}Yb$ were injected into mice and the mice were killed at 3, 24, and 48 hours following intraperitoneal injection of the radiopharmaceuticals. The retention value of $^{67}Ga$ and $^{169}Yb$ in tumor was similar but they differ from each other markedly in normal tissue distribution. $^{169}Yb$ citrate is cleared up from blood more rapidly than $^{67}Ga$ citrate, and a high tumor to blood ratio is achieved shortly after injection.

  • PDF

The Effects of 3-Isobutyl-1-methylxanthine (IBMX) on Nuclear and Cytoplasmic Maturation of Porcine Oocytes In Vitro

  • Kwak, Seong-Sung;Jang, Seung-Hoon;Jeong, Se-Heon;Jeon, Yubyeol;Biswas, Dibyendu;Hyun, Sang-Hwan
    • 한국수정란이식학회지
    • /
    • 제27권3호
    • /
    • pp.163-169
    • /
    • 2012
  • The 3-isobutyl-1-methylxanthine (IBMX) is non-selective phosphodiesterase and is able to prevent resumption of meiosis by maintaining elevated cyclic AMP (cAMP) concentrations in the oocyte. The present study was conducted to analyze: (1) nuclear maturation (examined by the Hoechst staining), (2) whether cytoplasmic maturation (examined by the intracellular glutathione (GSH) concentration) of porcine oocytes is improved during meiotic arrest after prematuration (22 h) with IBMX. Before in vitro maturation (IVM), oocytes were treated with 1 mM IBMX for 22 h. After 22 h of pre-maturation, the higher rate of IBMX treated group oocytes were arrested at the germinal vesicle (GV) stage (42.3%) than control IVM oocytes (10.1%). It appears that the effect of IBMX on the resumption of meiosis has shown clearly. In the end of IVM, the reversibility of the IBMX effect on the nuclear maturation has been corroborated in this study by the high proportions of MII stage oocytes (72.5%) reached after 44 h of IVM following the 22 h of inhibition. However, intracellular GSH concentrations were lower in the oocytes treated with IBMX than the control oocytes (6.78 and 12.94 pmol/oocyte, respectively). These results demonstrate that cytoplasmic maturation in porcine oocytes pre-treated with IBMX for 22 h did not equal that of control oocytes in the current IVM system. These results indicate that pre-maturation with IBMX for 22 h may not be beneficial in porcine IVM system.

방사성핵종을 이용한 치료에서 흡수선량의 평가 (Internal Radiation Dosimetry in Radionuclide Therapy)

  • 김경민;임상무
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제40권2호
    • /
    • pp.120-126
    • /
    • 2006
  • Radionuclide therapy has been continued for treatment of incurable diseases for past decades. Relevant evaluation of absorbed dose in radionuclide therapy is important to predict treatment output and essential for making treatment planning to prevent unexpected radiation toxicity. Many scientists in the field related with nuclear medicine have made effort to evolve concept and technique for internal radiation dosimetry in this review, basic concept of internal radiation dosimetry is described and recent progress in method for dosimetry is introduced.

시스템 개선을 통한 핵의학 검사실의 공간 선량률 감소방안 (Solution to Decrease Spatial Dose Rate in Laboratory of Nuclear Medicine through System Improvement)

  • 문재승;신민용;안성철;유문곤;김수근
    • 한국의료질향상학회지
    • /
    • 제20권1호
    • /
    • pp.60-73
    • /
    • 2014
  • Objectives: This study aims at decreasing spatial dose rate through work improvement whilst spatial dose rate is the cause of increasing personal exposure dose which occurs in the process of handling radioisotope. Methods: From February 2013 until July 2013, divided into "before" and "after" the improvement, spatial dose rate in laboratory of nuclear medicine was measured in gamma image room, PET/CT-1 image room, and PET/CT-2 image room as its locations. The measurement time was 08:00, 12:00 and 17:00, and SPSS 21.0 USA was opted for its statistical analysis. Result: The spatial dose rate at distribution worktable, injection table, the entrance to the distribution room, and radioisotope storage box, which had showed high spatial dose rate, decreased by more than 43.7% a monthly average. The distribution worktable, that had showed the highest spatial dose rate in PET/CT-1 image room, dropped the rate to 42.3% as of July. The injection table and distribution worktable in the PET/CT-2 image room also showed the decline of spatial dose rate to 89% and 64.4%, respectively. Conclusion: By improving distribution process and introducing proper radiation shielding material, we were able to drop the spatial dose rate substantially at distribution worktable, injection table, and nuclide storage box. However, taking into account of steadily increasing amount of radioisotope used, strengthening radiation related regulations, and safe utilization of radioisotope, the process of system improvement needs to be maintained through continuous monitoring.

$^{57}Co-BLM$을 이용한 종양진단 신티그라피에 관한 연구 (Clinical Evaluation of $^{57}Co-labelled$ Bleomycin for Tumor Localization)

  • 유용운;김장휘;이진오
    • 대한핵의학회지
    • /
    • 제21권1호
    • /
    • pp.61-68
    • /
    • 1987
  • Investigation with $^{57}Co-Bleomycin$ in patients with the various cancers and in tumor bearing animals are descirbed. In the patients, $^{57}Co-Bleomycin$ appears to be one of the useful tumor-seeking radiopharmaceuticals, and worth applicable to clinical uses. Labelled yield of $^{57}Co-Bleo$ was about 97 % by thin layer chromatography. The pyrogen free tests were performed to meet U.S.P. critical ranges. In clinical studies with $^{57}Co-Bleo$, 4 cases out of 5 patients with lung cancer., 2 cases among 3 thyroid cancer patients, and all 3 hepatoma patients showed positive tumor scans. The patients with stomach cancer, and the esophageal cancer showed false negative scintigraphy. A case with pulmonary tuberculosis showed a positive scan while liver abscess showed a negative picture. The merits of $^{57}Co-Bleomycin$ scintigraphy seems to be its relatively high affinity to tumors and low radiation hazard in spite of long physical half life.

  • PDF